Showing results (81-90 of 437) with videos related to

Sort By:
Pageof 44
Rheumatology (Oxford, England)|October 10, 2017
Interstitial lung disease points to consider for clinical trials in systemic sclerosisDinesh Khanna, James Seibold, Jonathan Goldin, et al.
Seminars in Arthritis and Rheumatism|July 9, 2019
Questioning a publication bias between industry-funded and non-industry-funded randomized controlled trials on biological and small molecule therapy for rheumatoid arthritisNeta Cohen, Ronnie Gur Lavie, Ya'ara Manor, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider for skin ulcers in systemic sclerosisFelice Galluccio, Yannick Allanore, Lázló Czirjak, et al.
Rheumatology and Therapy|March 19, 2020
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal TrialRoy Fleischmann, Daniel E Furst, Erin Connolly-Strong, et al.
Cells|July 11, 2025
Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic SclerosisCristiano Barbetta, Francesco Bonomi, Gemma Lepri, et al.
Rheumatology (Oxford, England)|October 10, 2017
Assessment of skin involvement in systemic sclerosisGábor Kumánovics, Márta Péntek, Sangmee Bae, et al.
Clinical and Experimental Rheumatology|June 14, 2012
Clinical trial design in scleroderma: where are we and where do we go next?Lorinda Chung, Christopher P Denton, Oliver Distler, et al.
Rheumatology (Oxford, England)|February 11, 2010
Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trialPuja P Khanna, Daniel E Furst, Philip J Clements, et al.
The Journal of Rheumatology|December 7, 2005
A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritisDaniel E Furst, Roy Fleischmann, Elliott Kopp, et al.
Rheumatology (Oxford, England)|February 18, 2011
Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life studyTracy Frech, Ron D Hays, Paul Maranian, et al.
Pageof 44